Legend Biotech (LEGN)
(Real Time Quote from BATS)
$37.39 USD
-0.27 (-0.72%)
Updated Aug 7, 2025 10:00 AM ET
3-Hold of 5 3
D Value D Growth A Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
LEGN 37.39 -0.27(-0.72%)
Will LEGN be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for LEGN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for LEGN
Legend Biotech (LEGN) Surges 6.0%: Is This an Indication of Further Gains?
What Makes Legend Biotech (LEGN) a New Buy Stock
LEGN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Wall Street Analysts Think Legend Biotech (LEGN) Could Surge 135.16%: Read This Before Placing a Bet
Legend Biotech (LEGN) Moves 5.1% Higher: Will This Strength Last?
Pacira (PCRX) Surges 14.7%: Is This an Indication of Further Gains?
Other News for LEGN
Why Johnson & Johnson Stock Still Has Room To Run
Legend Biotech to Host Investor Conference Call on Second Quarter 2025 Results | LEGN Stock News
Legend Biotech Corp (LEGN) Announces Upcoming Conference Call to Discuss Q2 2025 Results | LEGN ...
Looking Into Legend Biotech's Recent Short Interest
Legend Biotech (LEGN) Receives 'Buy' Rating from HC Wainwright & Co. | LEGN Stock News